Barely Significant
← all excerpts

CDK4/6 blockade provides an alternative approach for treatment of mismatch-repair deficient tumors.

Oncoimmunology · 2022 · PMC9278458 · PMID 35845723

1
hedged sentence
closest p
boldest claim

The sentences

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.